Complete list of publications

• 1

  21.10.2019

  The frequency of photosensitizing drug dispensings in Austria and Germany: A correlation with their photosensitizing potential based on published literature.

  ; Hofmann, G. ; Gradl, G. ; Schulz, M. ; Haidinger, G. ; Tanew, A. ; Weber, B.

  J Eur Acad Dermatol Venereol. 2019 Sep 14. doi: 10.1111/jdv.15952

  Conflicts of interest: None declared.

• 1

  21.10.2019

  Post-mortem analysis of prescription opioids - A follow-up examination by LC–MS/MS with focus on fentanyl

  ; Schönfeld, T. ; Heinemann, A. ; Schulz, M. ; Gradl, G. ; Andresen-Streichert, H. ; Müller, A. ; Iwersen-Bergmann, S.

  Forensic Sci Int. 2019 Oct 9;305:109970. doi: 10.1016/j.forsciint.2019.109970

  Conflicts of interest: None declared

• 1

  14.12.2018

  Fixkombinationen von Antihypertensiva auf dem deutschen Markt - Fixkombinationen von ACE-Hemmern, Angiotensin-II-Rezeptorblockern, Betablockern, Calciumkanalblockern und Diuretika

  ; Kieble, M. ; Enners, S. ; Schulz, M.

  Fixkombinationen von Antihypertensiva auf dem deutschen Markt_DAPI_Stand 15.11.2018

  Conflicts of interest: none declared.

• 1

  28.09.2018

  Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016

  ; Gradl, G. ; Teichert, M. ; Kieble, M. ; Werning, J. ; Schulz, M.

  KEYWORDS
  ambulatory care, anti‐bacterial agents, drug utilization, Germany, Netherlands,
  pharmacoepidemiology

  Pharmacoepidemiol Drug Saf. 2018;1–12. doi: 10.1002/pds.4643

  Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016

  Conflicts of interest: None declared

• 1

  30.05.2018

  Extemporaneous formulations in Germany - relevance for everyday clinical practice.

  ; Staubach-Renz, P. ; Salzmann, S. ; Peveling-Oberhag, A. ; Weyer, V. ; Zimmer, S. ; Gradl, G. ; Lang, B.

  J Dtsch Dermatol Ges. 2018 May;16(5):566-574. doi: 10.1111/ddg.13519.

  www.ncbi.nlm.nih.gov/pubmed/29750454

   

  Conflicts of interest: None declared

• 1

  15.01.2018

  In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

  ; Krüger, K. ; Griese-Mammen, N. ; Schubert, I. ; Kieble, M. ; Botermann, L. ; Laufs, U. ; Kloft, C. ; Schulz, M.

  Heart Fail Rev - 2018 Jan;23(1):63-71

  www.ncbi.nlm.nih.gov/pubmed/28993930

  Conflicts of interest: None declared

• 1

  16.10.2017

  Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison

  ; Gradl, G. ; Teichert, M. ; Kieble, M. ; Werning, J. ; Schulz, M.

  Poster 46th ESCP Symposium on Clinical Pharmacy (Best Poster Award).
  Heidelberg, 09.-11.10.2017. Programme and Abstract Book PE007, p. 166
  Int. J. Clin. Pharm. 40, 1 (2018) 295.

   

   

  ESCP-2017_Poster_PE007_Oral_antibiotics

  Conflicts of interest: None declared

• 1

  16.10.2017

  Temporal synchrony between drug dispensings and adverse drug events? The example of statins & rhabdomyolysis and metamizole or clozapine & agranulocytosis

  ; Schulz, M. ; Gradl, G. ; Laufs, U. ; Herdegen, T. ; Werning, J. ; Kieble, M. ; Bruckmüller, H. ; Klein, H. ; Böhm, R.

  Oral communication 46th ESCP Symposium on Clinical Pharmacy.
  Heidelberg, 11.10.2017. Programme and Abstract Book PE003, p. 64–65.
  Int. J. Clin Pharm. 40, 1 (2018) 210.

  ESCP-2017_Poster_PE003_Temporal_synchrony

  Conflicts of interest: None declared

• 1

  29.09.2017

  Anwendung pharmazeutischer Bedenken 2016 – Eine Auswertung des Deutschen Arzneiprüfungsinstitutes e. V. (DAPI)

  Informationsblatt der Sächsischen Landesapothekerkammer IV | 2017:33-36.

  Conflicts of interest: none declared.

• 1

  05.09.2016

  Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

  ; Gradl, G. ; Krieg, E. ; Schulz, M.

  Pharmacy Practice - 2016 Jul-Sep; 14(3):786

  Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

  SUPPLEMENT - Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

  Conflicts of interest: None declared.